ZYUS Life Sciences Corporation (CVE:ZYU – Free Report) – Equities research analysts at Stifel Canada issued their FY2025 earnings estimates for shares of ZYUS Life Sciences in a report issued on Thursday, September 19th. Stifel Canada analyst J. Keywood anticipates that the company will earn ($0.38) per share for the year.
ZYUS Life Sciences Stock Performance
ZYUS Life Sciences (CVE:ZYU – Get Free Report) last announced its quarterly earnings data on Wednesday, August 28th. The company reported C($0.07) EPS for the quarter, beating the consensus estimate of C($0.08) by C$0.01. The business had revenue of C$0.12 million during the quarter, compared to analysts’ expectations of C$0.11 million.
Recommended Stories
- Five stocks we like better than ZYUS Life Sciences
- Earnings Per Share Calculator: How to Calculate EPS
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- How to buy stock: A step-by-step guide for beginnersÂ
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- What is a SEC Filing?
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for ZYUS Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZYUS Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
